Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Nov. 30, 2017	Nov. 30, 2016
Cash Flows From Operating Activities:
Net Income	$ 21,682	$ 48,994
Adjustments To Reconcile Net Income To Net Cash Provided By Operating Activities:
Provision For Doubtful Accounts	2,940	18
Amortization and Depreciation	37,840	37,964
Deferred Income Tax Expense	2,362	(538)
Property, Plant and Equipment, Disposals	8,285	6,602
Net Loss (Gain) On Insurance Settlement or On Sale of Property, Plant & Equipment	576	26
Amortization of Deferred Borrowing Costs	450	952
Allocated Share-based Compensation Expense	4,810	4,408
Effects of Changes In Assets & Liabilities:
Accounts Receivable	(15,754)	(33,706)
Inventories	(11,744)	(6,795)
Prepaid Expenses and Other	(2,518)	(1,554)
Other Assets	(57)	(2,451)
Net Change In Billings Related To Costs and Estimated Earnings On Uncompleted Contracts	4,896	(3,277)
Accounts Payable	(5,867)	7,588
Other Accrued Liabilities and Income Taxes Payable	(9,191)	(956)
Net Cash Provided By Operating Activities	38,710	57,275
Cash Flows Used For Investing Activities:
Proceeds From Sale Or Insurance Settlement of Property, Plant, and Equipment	200	543
Purchase of Property, Plant and Equipment	(21,533)	(29,135)
Acquisition of Subsidiaries, Net of Cash Acquired	(32,841)	(22,679)
Net Cash From Investing Activities	(54,174)	(51,271)
Cash Flows From Financing Activities:
Proceeds from revolving loan	273,000	150,000
Payments on revolving loan	(174,500)	(144,000)
Payments on Long Term Debt	(63,505)	(20,848)
Payments for Repurchase of Common Stock	(7,518)	(5,282)
Payments of Dividends	(13,266)	(12,216)
Net Cash Used In Financing Activities	14,211	(32,346)
Effect of Exchange Rate Changes on Cash	602	(370)
Net Increase (Decrease) In Cash & Cash Equivalents	(651)	(26,712)
Cash & Cash Equivalents At Beginning of Period	11,302	40,191
Cash & Cash Equivalents At End of Period	10,651
Supplemental Disclosures
Cash Paid For Interest	8,948	9,291
Cash Paid For Income Taxes	$ 8,416	$ 17,768